{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:16:58Z","timestamp":1790223418368,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005902","name":"Institute for Clinical and Translational Research, University of Wisconsin, Madison","doi-asserted-by":"publisher","award":["T32AR055893"],"award-info":[{"award-number":["T32AR055893"]}],"id":[{"id":"10.13039\/100005902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR000427"],"award-info":[{"award-number":["UL1TR000427"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA014520"],"award-info":[{"award-number":["P30CA014520"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1038\/jid.2014.364","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T13:46:52Z","timestamp":1408542412000},"page":"861-868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["c-CBL E3 Ubiquitin Ligase Is Overexpressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation-Induced Cell Death"],"prefix":"10.1016","volume":"135","author":[{"given":"Jianqiang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin A.","family":"Salva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2014.364_bb0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1046\/j.1523-1747.2000.00147.x","article-title":"Involvement of Fas (APO-1\/CD95) during photodynamic therapy-mediated apoptosis in human epidermoid carcinoma A431 cells","volume":"115","author":"Ahmad","year":"2000","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.364_bb0015","first-page":"257","article-title":"Photodynamic therapy induced Fas-mediated apoptosis in human carcinoma cells","volume":"9","author":"Ali","year":"2002","journal-title":"Int J Mol Med"},{"key":"10.1038\/jid.2014.364_bb0020","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/sj.jid.5700868","article-title":"Blockade of death receptor-mediated pathways coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells","volume":"127","author":"Braun","year":"2007","journal-title":"J Investig Dermatol Symp Proc."},{"key":"10.1038\/jid.2014.364_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/jid.2011.316","article-title":"Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand","volume":"132","author":"Braun","year":"2012","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.364_bb0030","doi-asserted-by":"crossref","first-page":"7284","DOI":"10.1128\/MCB.00476-07","article-title":"Histone deacetylase inhibitors reduce steroidogenesis through SCF-mediated ubiquitination and degradation of steroidogenic factor 1 (NR5A1)","volume":"27","author":"Chen","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1038\/jid.2014.364_bb0035","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1182\/blood-2007-08-109074","article-title":"Resistance to FasL and TRAIL-mediated apoptosis in S\u00e9zary syndrome associated with impaired death receptor and FLIP expression","volume":"111","author":"Contassot","year":"2008","journal-title":"Blood"},{"key":"10.1038\/jid.2014.364_bb0040","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.leu.2400745","article-title":"Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk","volume":"11","author":"Fargnoli","year":"1997","journal-title":"Leukemia"},{"key":"10.1038\/jid.2014.364_bb0045","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1007\/s10495-006-0190-x","article-title":"Involvement of both caspase-dependent and -independent pathways in apoptotic induction by hexaminolevulinate-mediated photodynamic therapy in human lymphoma cells","volume":"11","author":"Furre","year":"2006","journal-title":"Apoptosis"},{"key":"10.1038\/jid.2014.364_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1756-8722-5-24","article-title":"Novel therapeutic agents for cutaneous T-cell lymphoma","volume":"5","author":"Jain","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1038\/jid.2014.364_bb0055","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1158\/0008-5472.CAN-08-4631","article-title":"Lack of T-cell receptor-induced signaling is crucial for CD95 ligand up-regulation and protects cutaneous T-cell lymphoma cells from activation-induced cell death","volume":"69","author":"Klemke","year":"2009","journal-title":"Cancer Res"},{"key":"10.1038\/jid.2014.364_bb0060","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1002\/cncr.26153","article-title":"An E3 ubiquitin ligase c-Cbl: a new therapeutic target of lung cancer in cell and animal models","volume":"117","author":"Lo","year":"2011","journal-title":"Cancer"},{"key":"10.1038\/jid.2014.364_bb0065","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4161\/cc.6.20.4797","article-title":"The ubiquitin E3 ligase Cbl-b in T-cell tolerance and tumor immunity","volume":"6","author":"Loeser","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1038\/jid.2014.364_bb0070","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nbt0710-682","article-title":"Inhibitors for E3 ubiquitin ligases","volume":"28","author":"Lydeard","year":"2010","journal-title":"Nature Biotech"},{"key":"10.1038\/jid.2014.364_bb0075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1749-6632.2001.tb03710.x","article-title":"Reversible resistance to apoptosis in cutaneous t cell lymphoma","volume":"941","author":"Meech","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/jid.2014.364_bb0080","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1200\/JCO.2010.32.0630","article-title":"Clinical endpoints and response criteria in mycosis fungoides and S\u00e9zary syndrome","volume":"29","author":"Olsen","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1038\/jid.2014.364_bb0085","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00281-010-0197-9","article-title":"Cbl-b in T-cell activation","volume":"32","author":"Paolino","year":"2010","journal-title":"Semin Immunopathol"},{"key":"10.1038\/jid.2014.364_bb0090","doi-asserted-by":"crossref","first-page":"632","DOI":"10.4049\/jimmunol.1202068","article-title":"T-cell activation threshold regulated by E3 ubiquitin ligase Cbl-b determines fate of inducible regulatory T-cells","volume":"191","author":"Qiao","year":"2013","journal-title":"J Immunol"},{"key":"10.1038\/jid.2014.364_bb0095","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1182\/blood-2013-09-525915","article-title":"Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and S\u00e9zary syndrome","volume":"123","author":"Querfeld","year":"2014","journal-title":"Blood"},{"key":"10.1038\/jid.2014.364_bb0100","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.leukres.2012.04.018","article-title":"Casitas B-cell lymphoma mutation in childhood T-cell acute lymphoblastic leukemia","volume":"36","author":"Saito","year":"2012","journal-title":"Leuk Res"},{"key":"10.1038\/jid.2014.364_bb0105","first-page":"S117","article-title":"Epigenetically enhanced photodynamic therapy (ePDT) is superior to conventional PDT for inducing apoptosis in cutaneous T-cell lymphoma (CTCL)","volume":"134","author":"Salva","year":"2014","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.364_bb0110","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nrm1762","article-title":"The CBL interactome and its functions","volume":"6","author":"Schmidt","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1038\/jid.2014.364_bb0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1078-0432.CCR-07-1419","article-title":"Inhibition of IKK in CTCL down-regulates NF-kB activation, induces cell death, and potentiates response to chemotherapeutic agents","volume":"14","author":"Sors","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1038\/jid.2014.364_bb0120","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.jaad.2012.05.035","article-title":"The Fas apoptotic pathway in cutaneous T-cell lymphomas: Frequent expression of phenotypes associated with resistance to apoptosis","volume":"67","author":"Stutz","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1038\/jid.2014.364_bb0125","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcp.20694","article-title":"The Cbl family proteins: ring leaders in regulation of cell signaling","volume":"209","author":"Swaminathan","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1038\/jid.2014.364_bb0130","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/jid.2008.309","article-title":"Low FAS\/CD95 expression in CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS up-regulation","volume":"129","author":"Wu","year":"2009","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1038\/jid.2014.364_bb0135","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/exd.12374","article-title":"Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues","volume":"23","author":"Wu","year":"2014","journal-title":"Exp Dermatol"},{"key":"10.1038\/jid.2014.364_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.abb.2010.10.020","article-title":"Structural alterations capable of affecting FAS\/CD95 gene function in cutaneous T-cell lymphoma (CTCL)","volume":"508","author":"Wu","year":"2011","journal-title":"Arch Biochem Biophys"},{"key":"10.1038\/jid.2014.364_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archdermatol.2010.376","article-title":"Reduction of FAS\/CD95 promoter methylation upregulates FAS protein and enhances sensitivity to apoptosis in cutaneous T-cell lymphoma","volume":"147","author":"Wu","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1038\/jid.2014.364_bb0150","first-page":"S32","article-title":"c-CBL ubiquitin E3 ligase is over-expressed in S\u00e9zary syndrome and its inhibition restores T-cell receptor signaling, upregulates FAS-ligand expression and promotes activation-induced cell death","volume":"134","author":"Wu","year":"2014","journal-title":"J Investig Dermatol Symp Proc"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15371359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15371359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T21:51:40Z","timestamp":1743976300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15371359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S0022202X15371359"],"URL":"https:\/\/doi.org\/10.1038\/jid.2014.364","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"c-CBL E3 Ubiquitin Ligase Is Overexpressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation-Induced Cell Death","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/jid.2014.364","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Society for Investigative Dermatology, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}